BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 33294263)

  • 1. ERα is a target for butein-induced growth suppression in breast cancer.
    Huang C; Xia X; He J; Liu Y; Shao Z; Hu T; Yu C; Liu X; Xu Q; Liu B; Liu N; Liao Y; Huang H
    Am J Cancer Res; 2020; 10(11):3721-3736. PubMed ID: 33294263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeting proteasome-associated deubiquitinases as a novel strategy for the treatment of estrogen receptor-positive breast cancer.
    Xia X; Liao Y; Guo Z; Li Y; Jiang L; Zhang F; Huang C; Liu Y; Wang X; Liu N; Liu J; Huang H
    Oncogenesis; 2018 Sep; 7(9):75. PubMed ID: 30250021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor alpha prevents bladder cancer via INPP4B inhibited akt pathway in vitro and in vivo.
    Hsu I; Yeh CR; Slavin S; Miyamoto H; Netto GJ; Tsai YC; Muyan M; Wu XR; Messing EM; Guancial EA; Yeh S
    Oncotarget; 2014 Sep; 5(17):7917-35. PubMed ID: 25277204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of estrogen receptor alpha protein level and survival function by DBC-1.
    Trauernicht AM; Kim SJ; Kim NH; Boyer TG
    Mol Endocrinol; 2007 Jul; 21(7):1526-36. PubMed ID: 17473282
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1-NDRG1 deregulation.
    Mayayo-Peralta I; Debets DO; Prekovic S; Schuurman K; Beerthuijzen S; Almekinders M; Sanders J; Moelans CB; Saleiro S; Wesseling J; van Diest PJ; Henrique R; Jerónimo C; Altelaar M; Zwart W
    Mol Oncol; 2024 Jan; 18(1):156-169. PubMed ID: 37854018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-135b regulates ERα, AR and HIF1AN and affects breast and prostate cancer cell growth.
    Aakula A; Leivonen SK; Hintsanen P; Aittokallio T; Ceder Y; Børresen-Dale AL; Perälä M; Östling P; Kallioniemi O
    Mol Oncol; 2015 Aug; 9(7):1287-300. PubMed ID: 25907805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IL-1 induces p62/SQSTM1 and autophagy in ERα
    Nawas AF; Mistry R; Narayanan S; Thomas-Jardin SE; Ramachandran J; Ravichandran J; Neduvelil E; Luangpanh K; Delk NA
    J Cell Biochem; 2019 Feb; 120(2):1477-1491. PubMed ID: 30324661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antiestrogens in combination with immune checkpoint inhibitors in breast cancer immunotherapy.
    Márquez-Garbán DC; Deng G; Comin-Anduix B; Garcia AJ; Xing Y; Chen HW; Cheung-Lau G; Hamilton N; Jung ME; Pietras RJ
    J Steroid Biochem Mol Biol; 2019 Oct; 193():105415. PubMed ID: 31226312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-1271 inhibits ERα expression and confers letrozole resistance in breast cancer.
    Yu T; Yu HR; Sun JY; Zhao Z; Li S; Zhang XF; Liao ZX; Cui MK; Li J; Li C; Zhang Q
    Oncotarget; 2017 Dec; 8(63):107134-107148. PubMed ID: 29291017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel antiestrogen agent Shikonin inhibits estrogen-dependent gene transcription in human breast cancer cells.
    Yao Y; Zhou Q
    Breast Cancer Res Treat; 2010 May; 121(1):233-40. PubMed ID: 19760501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast ERα promotes bladder cancer invasion via increasing the CCL1 and IL-6 signals in the tumor microenvironment.
    Yeh CR; Hsu I; Song W; Chang H; Miyamoto H; Xiao GQ; Li L; Yeh S
    Am J Cancer Res; 2015; 5(3):1146-57. PubMed ID: 26045993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Butein downregulates chemokine receptor CXCR4 expression and function through suppression of NF-κB activation in breast and pancreatic tumor cells.
    Chua AW; Hay HS; Rajendran P; Shanmugam MK; Li F; Bist P; Koay ES; Lim LH; Kumar AP; Sethi G
    Biochem Pharmacol; 2010 Nov; 80(10):1553-62. PubMed ID: 20699088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural, Thermodynamic, and Kinetic Traits of Antiestrogen-Compounds Selectively Targeting the Y537S Mutant Estrogen Receptor α Transcriptional Activity in Breast Cancer Cell Lines.
    Pavlin M; Gelsomino L; Barone I; Spinello A; Catalano S; Andò S; Magistrato A
    Front Chem; 2019; 7():602. PubMed ID: 31552220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suppression of ERβ signaling via ERβ knockout or antagonist protects against bladder cancer development.
    Hsu I; Chuang KL; Slavin S; Da J; Lim WX; Pang ST; O'Brien JH; Yeh S
    Carcinogenesis; 2014 Mar; 35(3):651-61. PubMed ID: 24148819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Butein inhibits NF-κB, AP-1 and Akt activation in adult T-cell leukemia/lymphoma.
    Ishikawa C; Senba M; Mori N
    Int J Oncol; 2017 Aug; 51(2):633-643. PubMed ID: 28586006
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen receptor α regulates non-canonical autophagy that provides stress resistance to neuroblastoma and breast cancer cells and involves BAG3 function.
    Felzen V; Hiebel C; Koziollek-Drechsler I; Reißig S; Wolfrum U; Kögel D; Brandts C; Behl C; Morawe T
    Cell Death Dis; 2015 Jul; 6(7):e1812. PubMed ID: 26158518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation.
    Zhuang T; Yu S; Zhang L; Yang H; Li X; Hou Y; Liu Z; Shi Y; Wang W; Yu N; Li A; Li X; Li X; Niu G; Xu J; Hasni MS; Mu K; Wang H; Zhu J
    Oncotarget; 2017 Sep; 8(44):77137-77151. PubMed ID: 29100376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Docosahexaenoic acid induces proteasome-dependent degradation of estrogen receptor alpha and inhibits the downstream signaling target in MCF-7 breast cancer cells.
    Lu IF; Hasio AC; Hu MC; Yang FM; Su HM
    J Nutr Biochem; 2010 Jun; 21(6):512-7. PubMed ID: 19369047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benzopyran derivative CDRI-85/287 induces G2-M arrest in estrogen receptor-positive breast cancer cells via modulation of estrogen receptors α- and β-mediated signaling, in parallel to EGFR signaling and suppresses the growth of tumor xenograft.
    Saxena R; Fatima I; Chandra V; Blesson CS; Kharkwal G; Hussain MK; Hajela K; Roy BG; Dwivedi A
    Steroids; 2013 Nov; 78(11):1071-86. PubMed ID: 23891847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.